Citadel Advisors’s XTL Biopharmaceuticals XTLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-25,211
| Closed | -$31.3K | – | 7149 |
|
|
2025
Q1 | $31.3K | Buy |
+25,211
| New | +$31.3K | ﹤0.01% | 5503 |
|
|
2024
Q3 | – | Sell |
-15,435
| Closed | -$36.6K | – | 6835 |
|
|
2024
Q2 | $36.6K | Buy |
15,435
+1,804
| +13% | +$4.28K | ﹤0.01% | 5265 |
|
|
2024
Q1 | $38.3K | Buy |
+13,631
| New | +$38.3K | ﹤0.01% | 5383 |
|
|
2021
Q4 | – | Sell |
-12,801
| Closed | -$56K | – | 7293 |
|
|
2021
Q3 | $56K | Buy |
+12,801
| New | +$56K | ﹤0.01% | 6086 |
|
|
2019
Q4 | – | Sell |
-18,254
| Closed | -$26K | – | 5203 |
|
|
2019
Q3 | $26K | Buy |
+18,254
| New | +$26K | ﹤0.01% | 4474 |
|
|
2018
Q3 | – | Sell |
-17,312
| Closed | -$33K | – | 4785 |
|
|
2018
Q2 | $33K | Buy |
+17,312
| New | +$33K | ﹤0.01% | 3976 |
|
|
2017
Q1 | – | Sell |
-16,635
| Closed | -$50K | – | 4241 |
|
|
2016
Q4 | $50K | Buy |
16,635
+2,517
| +18% | +$7.57K | ﹤0.01% | 3313 |
|
|
2016
Q3 | $67K | Buy |
+14,118
| New | +$67K | ﹤0.01% | 3256 |
|
|
2016
Q2 | – | Sell |
-3,172
| Closed | -$17K | – | 3979 |
|
|
2016
Q1 | $17K | Buy |
+3,172
| New | +$17K | ﹤0.01% | 3188 |
|